Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Biocryst Pharma Inc (BCRX)

Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioCryst Launches ORLADEYO® (berotralstat) in Ireland GlobeNewswire - Mon Nov 18, 1:00AM CST

BCRX : 7.07 (+0.57%)
BioCryst to Present at Upcoming Investor Conferences GlobeNewswire - Wed Nov 6, 6:00AM CST

BCRX : 7.07 (+0.57%)
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Tue Nov 5, 6:00AM CST

BCRX : 7.07 (+0.57%)
BioCryst Pharmaceuticals (BCRX) Q3 2024 Earnings Call Transcript Motley Fool - Mon Nov 4, 1:30PM CST

BCRX earnings call for the period ending September 30, 2024.

BCRX : 7.07 (+0.57%)
BioCryst: Q3 Earnings Snapshot AP - Mon Nov 4, 6:06AM CST

BioCryst: Q3 Earnings Snapshot

BCRX : 7.07 (+0.57%)
BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Mon Nov 4, 6:00AM CST

BCRX : 7.07 (+0.57%)
BioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat) GlobeNewswire - Thu Oct 24, 7:00AM CDT

BCRX : 7.07 (+0.57%)
BioCryst to Report Third Quarter 2024 Financial Results on November 4 GlobeNewswire - Mon Oct 21, 6:00AM CDT

BCRX : 7.07 (+0.57%)
BioCryst to Present New Real-World Evidence Showing Significant Reductions in Medical Visits and Hospitalizations After Starting ORLADEYO® (berotralstat) GlobeNewswire - Mon Oct 14, 6:00AM CDT

BCRX : 7.07 (+0.57%)
BioCryst to Present New Real-World Evidence on Long-Term Prophylaxis in HAE, including ORLADEYO® (berotralstat), at the American College of Allergy, Asthma & Immunology 2024 Annual Scientific Meeting GlobeNewswire - Thu Oct 10, 6:00AM CDT

BCRX : 7.07 (+0.57%)

Barchart Exclusives

3 No-Brainer AI Stocks to Consider for 2025 and Beyond Barchart - 31 minutes ago
These firms have carved out strong positions in their respective niches, making the stocks a no-brainer investment in the AI space. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot